{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:02:00Z","timestamp":1790622120469,"version":"4.1.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000073","name":"Autism Speaks","doi-asserted-by":"publisher","award":["11690"],"award-info":[{"award-number":["11690"]}],"id":[{"id":"10.13039\/100000073","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["operating funds"],"award-info":[{"award-number":["operating funds"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell'Istruzione, dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2017 N. SXEXT5"],"award-info":[{"award-number":["PRIN 2017 N. SXEXT5"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1038\/s41386-022-01454-7","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:04:00Z","timestamp":1663326240000},"page":"897-907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats"],"prefix":"10.1038","volume":"48","author":[{"given":"Sara","family":"Schiavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Manduca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Buzzelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Feo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Ascone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-8755","authenticated-orcid":false,"given":"Patrizia","family":"Campolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew N.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-6045","authenticated-orcid":false,"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"1454_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders - 5th ed. (DSM-5). Washington, DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1454_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(13)61539-1","volume":"383","author":"MC Lai","year":"2014","unstructured":"Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383:896\u2013910.","journal-title":"Lancet."},{"key":"1454_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrneurol.2013.278","volume":"10","author":"SS Jeste","year":"2014","unstructured":"Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol. 2014;10:74\u201381.","journal-title":"Nat Rev Neurol."},{"key":"1454_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.neubiorev.2014.01.006","volume":"46","author":"T Maurin","year":"2014","unstructured":"Maurin T, Zongaro S, Bardoni B. Fragile X Syndrome: from molecular pathology to therapy. Neurosci Biobehav Rev. 2014;46:242\u201355.","journal-title":"Neurosci Biobehav Rev"},{"key":"1454_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta7160","volume":"7","author":"FJ Song","year":"2003","unstructured":"Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. Screening for fragile X syndrome: a literature review and modelling study. Health Technol Assess. 2003;7:1\u2013106.","journal-title":"Health Technol Assess"},{"key":"1454_CR6","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ajmg.a.32848","volume":"149A","author":"RN Hernandez","year":"2009","unstructured":"Hernandez RN, Feinberg RL, Vaurio R, Passanante NM, Thompson RE, Kaufmann WE. Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am J Med Genet Part A. 2009;149A:1125\u201337.","journal-title":"Am J Med Genet Part A."},{"key":"1454_CR7","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB Jr., Moine H, Kooy RF, et al. Fragile X syndrome. Nat Rev Dis Prim. 2017;3:17065.","journal-title":"Nat Rev Dis Prim"},{"key":"1454_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnmol.2019.00051","volume":"12","author":"M Telias","year":"2019","unstructured":"Telias M. Molecular Mechanisms of Synaptic Dysregulation in Fragile X Syndrome and Autism Spectrum Disorders. Front Mol Neurosci. 2019;12:51.","journal-title":"Front Mol Neurosci"},{"key":"1454_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41593-018-0287-x","volume":"22","author":"SS Tran","year":"2019","unstructured":"Tran SS, Jun HI, Bahn JH, Azghadi A, Ramaswami G, Van Nostrand EL, et al. Widespread RNA editing dysregulation in brains from autistic individuals. Nat Neurosci. 2019;22:25\u201336.","journal-title":"Nat Neurosci"},{"key":"1454_CR10","doi-asserted-by":"crossref","unstructured":"Fyke W, Velinov M. FMR1 and Autism, an Intriguing Connection Revisited. Genes. 2021;12:1218.","DOI":"10.3390\/genes12081218"},{"key":"1454_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fnsyn.2017.00015","volume":"9","author":"S Castagnola","year":"2017","unstructured":"Castagnola S, Bardoni B, Maurin T. The Search for an Effective Therapy to Treat Fragile X Syndrome: Dream or Reality? Front Synaptic Neurosci. 2017;9:15.","journal-title":"Front Synaptic Neurosci"},{"key":"1454_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuropharm.2017.06.017","volume":"124","author":"A Araque","year":"2017","unstructured":"Araque A, Castillo PE, Manzoni OJ, Tonini R. Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 2017;124:13\u201324.","journal-title":"Neuropharmacology"},{"key":"1454_CR13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1038\/s41386-018-0135-4","volume":"43","author":"A Segev","year":"2018","unstructured":"Segev A, Korem N, Mizrachi Zer-Aviv T, Abush H, Lange R, Sauber G, et al. Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2018;43:2017\u201327.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"1454_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.31887\/DCNS.2020.22.3\/rmaldonado","volume":"22","author":"R Maldonado","year":"2020","unstructured":"Maldonado R, Cabanero D, Martin-Garcia E. The endocannabinoid system in modulating fear, anxiety, and stress. Dialogues Clin Neurosci. 2020;22:229\u201339.","journal-title":"Dialogues Clin Neurosci"},{"key":"1454_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tins.2017.04.005","volume":"40","author":"D Wei","year":"2017","unstructured":"Wei D, Allsop S, Tye K, Piomelli D. Endocannabinoid Signaling in the Control of Social Behavior. Trends Neurosci. 2017;40:385\u201396.","journal-title":"Trends Neurosci"},{"key":"1454_CR16","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.neuron.2019.02.041","volume":"101","author":"C Bagni","year":"2019","unstructured":"Bagni C, Zukin RS. A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders. Neuron 2019;101:1070\u201388.","journal-title":"Neuron"},{"key":"1454_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neubiorev.2019.04.012","volume":"110","author":"T Takumi","year":"2020","unstructured":"Takumi T, Tamada K, Hatanaka F, Nakai N, Bolton PF. Behavioral neuroscience of autism. Neurosci Biobehav Rev. 2020;110:60\u201376.","journal-title":"Neurosci Biobehav Rev"},{"key":"1454_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","volume":"76","author":"PE Castillo","year":"2012","unstructured":"Castillo PE, Younts TJ, Chavez AE, Hashimotodani Y. Endocannabinoid signaling and synaptic function. Neuron 2012;76:70\u201381.","journal-title":"Neuron"},{"key":"1454_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.conb.2014.03.017","volume":"29","author":"T Ohno-Shosaku","year":"2014","unstructured":"Ohno-Shosaku T, Kano M. Endocannabinoid-mediated retrograde modulation of synaptic transmission. Curr Opin Neurobiol. 2014;29:1\u20138.","journal-title":"Curr Opin Neurobiol"},{"key":"1454_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd1495","volume":"3","author":"V Di Marzo","year":"2004","unstructured":"Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov. 2004;3:771\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"1454_CR21","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003;4:873\u201384.","journal-title":"Nat Rev Neurosci."},{"key":"1454_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16:9\u201329.","journal-title":"Nat Rev Neurol."},{"key":"1454_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-019-0256-6","volume":"10","author":"A Aran","year":"2019","unstructured":"Aran A, Eylon M, Harel M, Polianski L, Nemirovski A, Tepper S, et al. Lower circulating endocannabinoid levels in children with autism spectrum disorder. Mol Autism. 2019;10:2.","journal-title":"Mol Autism"},{"key":"1454_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0203-y","volume":"9","author":"DS Karhson","year":"2018","unstructured":"Karhson DS, Krasinska KM, Dallaire JA, Libove RA, Phillips JM, Chien AS, et al. Plasma anandamide concentrations are lower in children with autism spectrum disorder. Mol Autism. 2018;9:18.","journal-title":"Mol Autism"},{"key":"1454_CR25","doi-asserted-by":"publisher","first-page":"e0187926","DOI":"10.1371\/journal.pone.0187926","volume":"12","author":"DR Smith","year":"2017","unstructured":"Smith DR, Stanley CM, Foss T, Boles RG, McKernan K. Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans. PloS ONE. 2017;12:e0187926.","journal-title":"PloS ONE"},{"key":"1454_CR26","doi-asserted-by":"publisher","first-page":"114256","DOI":"10.1016\/j.psychres.2021.114256","volume":"306","author":"M De Pol","year":"2021","unstructured":"De Pol M, Kolla NJ. Endocannabinoid markers in autism spectrum disorder: a scoping review of human studies. Psychiatry Res. 2021;306:114256.","journal-title":"Psychiatry Res"},{"key":"1454_CR27","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.neubiorev.2021.11.031","volume":"132","author":"S Pietropaolo","year":"2022","unstructured":"Pietropaolo S, Marsicano G. The role of the endocannabinoid system as a therapeutic target for autism spectrum disorder: Lessons from behavioral studies on mouse models. Neurosci Biobehav Rev. 2022;132:664\u201378.","journal-title":"Neurosci Biobehav Rev"},{"key":"1454_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.12.009","volume":"121","author":"E Carbone","year":"2021","unstructured":"Carbone E, Manduca A, Cacchione C, Vicari S, Trezza V. Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story. Neurosci Biobehav Rev. 2021;121:128\u201343.","journal-title":"Neurosci Biobehav Rev"},{"key":"1454_CR29","doi-asserted-by":"publisher","first-page":"107878","DOI":"10.1016\/j.pharmthera.2021.107878","volume":"226","author":"E Zamberletti","year":"2021","unstructured":"Zamberletti E, Rubino T, Parolaro D. Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder. Pharmacol Ther. 2021;226:107878.","journal-title":"Pharmacol Ther"},{"key":"1454_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/brain\/awab246","volume":"145","author":"MJ Hurley","year":"2022","unstructured":"Hurley MJ, Deacon RMJ, Chan AWE, Baker D, Selwood DL, Cogram P. Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice. Brain: J Neurol. 2022;145:76\u201382.","journal-title":"Brain: J Neurol"},{"key":"1454_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nm.3127","volume":"19","author":"A Busquets-Garcia","year":"2013","unstructured":"Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S, et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med. 2013;19:603\u20137.","journal-title":"Nat Med"},{"key":"1454_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2045","volume":"3","author":"KM Jung","year":"2012","unstructured":"Jung KM, Sepers M, Henstridge CM, Lassalle O, Neuhofer D, Martin H, et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat Commun. 2012;3:1080.","journal-title":"Nat Commun"},{"key":"1454_CR33","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1021\/acschemneuro.7b00398","volume":"9","author":"D Neuhofer","year":"2018","unstructured":"Neuhofer D, Lassalle O, Manzoni OJ. Muscarinic M1 Receptor Modulation of Synaptic Plasticity in Nucleus Accumbens of Wild-Type and Fragile X Mice. ACS Chem Neurosci. 2018;9:2233\u201340.","journal-title":"ACS Chem Neurosci"},{"key":"1454_CR34","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/mp.2017.221","volume":"23","author":"W Wang","year":"2018","unstructured":"Wang W, Cox BM, Jia Y, Le AA, Cox CD, Jung KM, et al. Treating a novel plasticity defect rescues episodic memory in Fragile X model mice. Mol Psychiatry. 2018;23:1798\u2013806.","journal-title":"Mol Psychiatry"},{"key":"1454_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-019-9277-x","volume":"11","author":"H Heussler","year":"2019","unstructured":"Heussler H, Cohen J, Silove N, Tich N, Bonn-Miller MO, Du W, et al. A phase 1\/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome. J Neurodev Disord. 2019;11:16.","journal-title":"J Neurodev Disord"},{"key":"1454_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/can.2018.0053","volume":"4","author":"N Tartaglia","year":"2019","unstructured":"Tartaglia N, Bonn-Miller M, Hagerman R. Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature. Cannabis Cannabinoid Res. 2019;4:3\u20139.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1454_CR37","doi-asserted-by":"crossref","unstructured":"Berry-Kravis EHR, Budimirovic D, Erickson C, Heussler H, Tartaglia N, Cohen J, et al. A Pivotal Study of ZYN002 Cannabidiol (CBD) Transdermal Gel in Children and Adolescents With Fragile X Syndrome. Biological Psychiatry. 2021;89:S226\u2013S7.","DOI":"10.1016\/j.biopsych.2021.02.571"},{"key":"1454_CR38","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1080\/1028415X.2020.1819107","volume":"25","author":"S Schiavi","year":"2022","unstructured":"Schiavi S, Carbone E, Melancia F, Buzzelli V, Manduca A, Campolongo P, et al. Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats. Nutritional Neurosci. 2022;25:898\u2013911.","journal-title":"Nutritional Neurosci"},{"key":"1454_CR39","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1093\/cercor\/bhz029","volume":"29","author":"CEM Golden","year":"2019","unstructured":"Golden CEM, Breen MS, Koro L, Sonar S, Niblo K, Browne A, et al. Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats. Cereb Cortex. 2019;29:2228\u201344.","journal-title":"Cereb Cortex"},{"key":"1454_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1037\/a0035988","volume":"128","author":"SM Hamilton","year":"2014","unstructured":"Hamilton SM, Green JR, Veeraragavan S, Yuva L, McCoy A, Wu Y, et al. Fmr1 and Nlgn3 knockout rats: novel tools for investigating autism spectrum disorders. Behav Neurosci. 2014;128:103\u20139.","journal-title":"Behav Neurosci"},{"key":"1454_CR41","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1093\/hmg\/ddv299","volume":"24","author":"SM Till","year":"2015","unstructured":"Till SM, Asiminas A, Jackson AD, Katsanevaki D, Barnes SA, Osterweil EK, et al. Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS. Hum Mol Genet. 2015;24:5977\u201384.","journal-title":"Hum Mol Genet"},{"key":"1454_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-01885-2","volume":"12","author":"S Schiavi","year":"2022","unstructured":"Schiavi S, Carbone E, Melancia F, di Masi A, Jarjat M, Brau F, et al. Phosphodiesterase 2A inhibition corrects the aberrant behavioral traits observed in genetic and environmental preclinical models of Autism Spectrum Disorder. Transl Psychiatry. 2022;12:119.","journal-title":"Transl Psychiatry"},{"key":"1454_CR43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.tins.2007.12.005","volume":"31","author":"DG Amaral","year":"2008","unstructured":"Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci. 2008;31:137\u201345.","journal-title":"Trends Neurosci"},{"key":"1454_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5607\/en.2015.24.4.273","volume":"24","author":"S Ha","year":"2015","unstructured":"Ha S, Sohn IJ, Kim N, Sim HJ, Cheon KA. Characteristics of Brains in Autism Spectrum Disorder: Structure, Function and Connectivity across the Lifespan. Exp Neurobiol. 2015;24:273\u201384.","journal-title":"Exp Neurobiol"},{"key":"1454_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00921-3","volume":"10","author":"S Hashem","year":"2020","unstructured":"Hashem S, Nisar S, Bhat AA, Yadav SK, Azeem MW, Bagga P, et al. Genetics of structural and functional brain changes in autism spectrum disorder. Transl Psychiatry. 2020;10:229.","journal-title":"Transl Psychiatry"},{"key":"1454_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02994-6","volume":"11","author":"K Fereshetyan","year":"2021","unstructured":"Fereshetyan K, Chavushyan V, Danielyan M, Yenkoyan K. Assessment of behavioral, morphological and electrophysiological changes in prenatal and postnatal valproate induced rat models of autism spectrum disorder. Sci Rep. 2021;11:23471.","journal-title":"Sci Rep."},{"key":"1454_CR47","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/syn.21759","volume":"68","author":"N Sosa-Diaz","year":"2014","unstructured":"Sosa-Diaz N, Bringas ME, Atzori M, Flores G. Prefrontal cortex, hippocampus, and basolateral amygdala plasticity in a rat model of autism spectrum. Synapse 2014;68:468\u201373.","journal-title":"Synapse"},{"key":"1454_CR48","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"1454_CR49","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3389\/fncel.2019.00479","volume":"13","author":"S Schiavi","year":"2019","unstructured":"Schiavi S, Iezzi D, Manduca A, Leone S, Melancia F, Carbone C, et al. Reward-Related Behavioral, Neurochemical and Electrophysiological Changes in a Rat Model of Autism Based on Prenatal Exposure to Valproic Acid. Front Cell Neurosci. 2019;13:479.","journal-title":"Front Cell Neurosci"},{"key":"1454_CR50","doi-asserted-by":"publisher","first-page":"18333","DOI":"10.1073\/pnas.1420285111","volume":"111","author":"M Morena","year":"2014","unstructured":"Morena M, Roozendaal B, Trezza V, Ratano P, Peloso A, Hauer D, et al. Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training. Proc Natl Acad Sci USA. 2014;111:18333\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1454_CR51","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","volume":"35","author":"JM Gray","year":"2015","unstructured":"Gray JM, Vecchiarelli HA, Morena M, Lee TT, Hermanson DJ, Kim AB, et al. Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety. J Neurosci: Off J Soc Neurosci. 2015;35:3879\u201392.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR52","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1002\/rcm.7277","volume":"29","author":"M Qi","year":"2015","unstructured":"Qi M, Morena M, Vecchiarelli HA, Hill MN, Schriemer DC. A robust capillary liquid chromatography\/tandem mass spectrometry method for quantitation of neuromodulatory endocannabinoids. Rapid Commun Mass Spectrom. 2015;29:1889\u201397.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1454_CR53","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc"},{"key":"1454_CR54","doi-asserted-by":"crossref","unstructured":"Santori A, Morena M, Hill MN, Campolongo P. Hippocampal 2-Arachidonoyl Glycerol Signaling Regulates Time-of-Day- and Stress-Dependent Effects on Rat Short-Term Memory. Int J Mol Sci. 2020;21:7316.","DOI":"10.3390\/ijms21197316"},{"key":"1454_CR55","doi-asserted-by":"publisher","first-page":"14899","DOI":"10.1523\/JNEUROSCI.0114-12.2012","volume":"32","author":"V Trezza","year":"2012","unstructured":"Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, et al. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. J Neurosci: Off J Soc Neurosci. 2012;32:14899\u2013908.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR56","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.euroneuro.2014.05.009","volume":"24","author":"A Manduca","year":"2014","unstructured":"Manduca A, Servadio M, Campolongo P, Palmery M, Trabace L, Vanderschuren LJ, et al. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol. 2014;24:1337\u201348.","journal-title":"Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol"},{"key":"1454_CR57","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nm803","volume":"9","author":"S Kathuria","year":"2003","unstructured":"Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med. 2003;9:76\u201381.","journal-title":"Nat Med"},{"key":"1454_CR58","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1124\/jpet.104.078980","volume":"313","author":"D Fegley","year":"2005","unstructured":"Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, et al. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3\u2019-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther. 2005;313:352\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"1454_CR59","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1111\/bph.14435","volume":"175","author":"F Melancia","year":"2018","unstructured":"Melancia F, Schiavi S, Servadio M, Cartocci V, Campolongo P, Palmery M, et al. Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling. Br J Pharmacol. 2018;175:3699\u2013712.","journal-title":"Br J Pharmacol"},{"key":"1454_CR60","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/npp.2017.305","volume":"43","author":"M Morena","year":"2018","unstructured":"Morena M, Berardi A, Colucci P, Palmery M, Trezza V, Hill MN, et al. Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2018;43:1284\u201396.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"1454_CR61","doi-asserted-by":"publisher","first-page":"13962","DOI":"10.1523\/JNEUROSCI.1983-15.2015","volume":"35","author":"M Morena","year":"2015","unstructured":"Morena M, De Castro V, Gray JM, Palmery M, Trezza V, Roozendaal B, et al. Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats. J Neurosci: Off J Soc Neurosci. 2015;35:13962\u201374.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1527-3458.2006.00021.x","volume":"12","author":"D Piomelli","year":"2006","unstructured":"Piomelli D, Tarzia G, Duranti A, Tontini A, Mor M, Compton TR, et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev. 2006;12:21\u201338.","journal-title":"CNS Drug Rev"},{"key":"1454_CR63","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fnbeh.2016.00211","volume":"10","author":"A Manduca","year":"2016","unstructured":"Manduca A, Lassalle O, Sepers M, Campolongo P, Cuomo V, Marsicano G, et al. Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play. Front Behav Neurosci. 2016;10:211.","journal-title":"Front Behav Neurosci"},{"key":"1454_CR64","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1523\/JNEUROSCI.3516-16.2017","volume":"37","author":"A Manduca","year":"2017","unstructured":"Manduca A, Bara A, Larrieu T, Lassalle O, Joffre C, Laye S, et al. Amplification of mGlu5-Endocannabinoid Signaling Rescues Behavioral and Synaptic Deficits in a Mouse Model of Adolescent and Adult Dietary Polyunsaturated Fatty Acid Imbalance. J Neurosci: Off J Soc Neurosci. 2017;37:6851\u201368.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR65","doi-asserted-by":"crossref","unstructured":"Bara A, Manduca A, Bernabeu A, Borsoi M, Serviado M, Lassalle O, et al. Sex-dependent effects of in utero cannabinoid exposure on cortical function. eLife. 2018;7:e36234.","DOI":"10.7554\/eLife.36234"},{"key":"1454_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnbeh.2019.00023","volume":"13","author":"M Borsoi","year":"2019","unstructured":"Borsoi M, Manduca A, Bara A, Lassalle O, Pelissier-Alicot AL, Manzoni OJ. Sex Differences in the Behavioral and Synaptic Consequences of a Single in vivo Exposure to the Synthetic Cannabimimetic WIN55,212-2 at Puberty and Adulthood. Front Behav Neurosci. 2019;13:23.","journal-title":"Front Behav Neurosci"},{"key":"1454_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.182","volume":"6","author":"M Servadio","year":"2016","unstructured":"Servadio M, Melancia F, Manduca A, di Masi A, Schiavi S, Cartocci V, et al. Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid. Transl Psychiatry. 2016;6:e902.","journal-title":"Transl Psychiatry"},{"key":"1454_CR68","doi-asserted-by":"crossref","unstructured":"Gomis-Gonzalez M, Busquets-Garcia A, Matute C, Maldonado R, Mato S, Ozaita A. Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model. Genes. 2016;7:56.","DOI":"10.3390\/genes7090056"},{"key":"1454_CR69","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1523\/JNEUROSCI.0795-10.2010","volume":"30","author":"L Zhang","year":"2010","unstructured":"Zhang L, Alger BE. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci: Off J Soc Neurosci. 2010;30:5724\u20139.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR70","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fncel.2015.00100","volume":"9","author":"D Neuhofer","year":"2015","unstructured":"Neuhofer D, Henstridge CM, Dudok B, Sepers M, Lassalle O, Katona I, et al. Functional and structural deficits at accumbens synapses in a mouse model of Fragile X. Front Cell Neurosci. 2015;9:100.","journal-title":"Front Cell Neurosci"},{"key":"1454_CR71","first-page":"5592","volume":"27","author":"HGS Martin","year":"2017","unstructured":"Martin HGS, Lassalle O, Manzoni OJ. Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse. Cereb Cortex. 2017;27:5592\u2013602.","journal-title":"Cereb Cortex"},{"key":"1454_CR72","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/npp.2010.19","volume":"35","author":"M Maccarrone","year":"2010","unstructured":"Maccarrone M, Rossi S, Bari M, De Chiara V, Rapino C, Musella A, et al. Abnormal mGlu 5 receptor\/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2010;35:1500\u20139.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"1454_CR73","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0959-4388(96)80076-6","volume":"6","author":"M Gallagher","year":"1996","unstructured":"Gallagher M, Chiba AA. The amygdala and emotion. Curr Opin Neurobiol. 1996;6:221\u20137.","journal-title":"Curr Opin Neurobiol"},{"key":"1454_CR74","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000356422","volume":"34","author":"B Opitz","year":"2014","unstructured":"Opitz B. Memory function and the hippocampus. Front Neurol Neurosci. 2014;34:51\u20139.","journal-title":"Front Neurol Neurosci"},{"key":"1454_CR75","doi-asserted-by":"crossref","unstructured":"Weston CSE. Four Social Brain Regions, Their Dysfunctions, and Sequelae, Extensively Explain Autism Spectrum Disorder Symptomatology. Brain Sci. 2019;9:130.","DOI":"10.3390\/brainsci9060130"},{"key":"1454_CR76","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/npp.2014.172","volume":"40","author":"LM Hernandez","year":"2015","unstructured":"Hernandez LM, Rudie JD, Green SA, Bookheimer S, Dapretto M. Neural signatures of autism spectrum disorders: insights into brain network dynamics. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2015;40:171\u201389.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"1454_CR77","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.nlm.2016.06.016","volume":"133","author":"RW Stackman Jr.","year":"2016","unstructured":"Stackman RW Jr., Cohen SJ, Lora JC, Rios LM. Temporary inactivation reveals that the CA1 region of the mouse dorsal hippocampus plays an equivalent role in the retrieval of long-term object memory and spatial memory. Neurobiol Learn Mem. 2016;133:118\u201328.","journal-title":"Neurobiol Learn Mem"},{"key":"1454_CR78","doi-asserted-by":"publisher","first-page":"10721","DOI":"10.1523\/JNEUROSCI.6413-10.2011","volume":"31","author":"GR Barker","year":"2011","unstructured":"Barker GR, Warburton EC. When is the hippocampus involved in recognition memory? J Neurosci: Off J Soc Neurosci. 2011;31:10721\u201331.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"1454_CR79","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbr.2014.09.050","volume":"285","author":"EC Warburton","year":"2015","unstructured":"Warburton EC, Brown MW. Neural circuitry for rat recognition memory. Behav Brain Res. 2015;285:131\u20139.","journal-title":"Behav Brain Res"},{"key":"1454_CR80","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.aaf7003","volume":"353","author":"T Okuyama","year":"2016","unstructured":"Okuyama T, Kitamura T, Roy DS, Itohara S, Tonegawa S. Ventral CA1 neurons store social memory. Science 2016;353:1536\u201341.","journal-title":"Science"},{"key":"1454_CR81","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1476-5381.2012.02095.x","volume":"167","author":"E Zamberletti","year":"2012","unstructured":"Zamberletti E, Piscitelli F, Cadeddu F, Rubino T, Fratta W, Fadda P, et al. Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation. Br J Pharmacol. 2012;167:1652\u201364.","journal-title":"Br J Pharmacol"},{"key":"1454_CR82","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1017\/S1461145710001185","volume":"15","author":"E Zamberletti","year":"2012","unstructured":"Zamberletti E, Vigano D, Guidali C, Rubino T, Parolaro D. Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. Int J Neuropsychopharmacol. 2012;15:267\u201380.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1454_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.brainres.2010.04.031","volume":"1343","author":"SA Robinson","year":"2010","unstructured":"Robinson SA, Loiacono RE, Christopoulos A, Sexton PM, Malone DT. The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Res. 2010;1343:153\u201367.","journal-title":"Brain Res"},{"key":"1454_CR84","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neuroscience.2007.10.043","volume":"152","author":"DT Malone","year":"2008","unstructured":"Malone DT, Kearn CS, Chongue L, Mackie K, Taylor DA. Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats. Neuroscience 2008;152:265\u201372.","journal-title":"Neuroscience"},{"key":"1454_CR85","doi-asserted-by":"publisher","first-page":"734837","DOI":"10.3389\/fpsyt.2021.734837","volume":"12","author":"T Su","year":"2021","unstructured":"Su T, Yan Y, Li Q, Ye J, Pei L. Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia. Front Psychiatry. 2021;12:734837.","journal-title":"Front Psychiatry"},{"key":"1454_CR86","doi-asserted-by":"crossref","unstructured":"Zamberletti E, Gabaglio M, Parolaro D. The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models. Int J Mol Sci. 2017;18:1916.","DOI":"10.3390\/ijms18091916"},{"key":"1454_CR87","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.bbr.2015.05.003","volume":"291","author":"M Qin","year":"2015","unstructured":"Qin M, Zeidler Z, Moulton K, Krych L, Xia Z, Smith CB. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome. Behav Brain Res. 2015;291:164\u201371.","journal-title":"Behav Brain Res"},{"key":"1454_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/can.2015.0008","volume":"1","author":"D Wei","year":"2016","unstructured":"Wei D, Dinh D, Lee D, Li D, Anguren A, Moreno-Sanz G, et al. Enhancement of Anandamide-Mediated Endocannabinoid Signaling Corrects Autism-Related Social Impairment. Cannabis Cannabinoid Res. 2016;1:81\u20139.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1454_CR89","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","volume":"113","author":"DM Kerr","year":"2016","unstructured":"Kerr DM, Gilmartin A, Roche M. Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid. Pharmacol Res. 2016;113:228\u201335.","journal-title":"Pharmacol Res"},{"key":"1454_CR90","doi-asserted-by":"publisher","first-page":"107736","DOI":"10.1016\/j.neuropharm.2019.107736","volume":"162","author":"HF Wu","year":"2020","unstructured":"Wu HF, Lu TY, Chu MC, Chen PS, Lee CW, Lin HC. Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism. Neuropharmacology 2020;162:107736.","journal-title":"Neuropharmacology"},{"key":"1454_CR91","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbi.2016.07.152","volume":"58","author":"VM Doenni","year":"2016","unstructured":"Doenni VM, Gray JM, Song CM, Patel S, Hill MN, Pittman QJ. Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Brain Behav Immun. 2016;58:237\u201347.","journal-title":"Brain Behav Immun"},{"key":"1454_CR92","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnbeh.2011.00034","volume":"5","author":"I Akirav","year":"2011","unstructured":"Akirav I. The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus. Front Behav Neurosci. 2011;5:34.","journal-title":"Front Behav Neurosci"},{"key":"1454_CR93","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-3-540-88955-7_8","volume":"1","author":"G Marsicano","year":"2009","unstructured":"Marsicano G, Lafenetre P. Roles of the endocannabinoid system in learning and memory. Curr Top Behav Neurosci. 2009;1:201\u201330.","journal-title":"Curr Top Behav Neurosci"},{"key":"1454_CR94","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41386-018-0274-7","volume":"44","author":"T Zimmermann","year":"2019","unstructured":"Zimmermann T, Bartsch JC, Beer A, Lomazzo E, Guggenhuber S, Lange MD, et al. Impaired anandamide\/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2019;44:1377\u201388.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol"},{"key":"1454_CR95","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hipo.22272","volume":"24","author":"BS Basavarajappa","year":"2014","unstructured":"Basavarajappa BS, Nagre NN, Xie S, Subbanna S. Elevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice. Hippocampus 2014;24:808\u201318.","journal-title":"Hippocampus"},{"key":"1454_CR96","doi-asserted-by":"crossref","unstructured":"Robledo-Menendez A, Vella M, Grandes P, Soria-Gomez E. Cannabinoid control of hippocampal functions: the where matters. FEBS J. 2022;289:2162\u201375.","DOI":"10.1111\/febs.15907"},{"key":"1454_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.04.002","volume":"56","author":"A Straiker","year":"2013","unstructured":"Straiker A, Min KT, Mackie K. Fmr1 deletion enhances and ultimately desensitizes CB(1) signaling in autaptic hippocampal neurons. Neurobiol Dis. 2013;56:1\u20135.","journal-title":"Neurobiol Dis"},{"key":"1454_CR98","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","volume":"38","author":"GG Gould","year":"2012","unstructured":"Gould GG, Seillier A, Weiss G, Giuffrida A, Burke TF, Hensler JG, et al. Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Prog neuro-Psychopharmacol Biol Psychiatry. 2012;38:260\u20139.","journal-title":"Prog neuro-Psychopharmacol Biol Psychiatry"},{"key":"1454_CR99","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/157015911795017047","volume":"9","author":"ES Onaivi","year":"2011","unstructured":"Onaivi ES, Benno R, Halpern T, Mehanovic M, Schanz N, Sanders C, et al. Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. Curr Neuropharmacol. 2011;9:209\u201314.","journal-title":"Curr Neuropharmacol"},{"key":"1454_CR100","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/sj.bjp.0705467","volume":"140","author":"RA Ross","year":"2003","unstructured":"Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol. 2003;140:790\u2013801.","journal-title":"Br J Pharmacol"},{"key":"1454_CR101","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biopsych.2017.11.036","volume":"84","author":"BC Shonesy","year":"2018","unstructured":"Shonesy BC, Parrish WP, Haddad HK, Stephenson JR, Baldi R, Bluett RJ, et al. Role of Striatal Direct Pathway 2-Arachidonoylglycerol Signaling in Sociability and Repetitive Behavior. Biol Psychiatry. 2018;84:304\u201315.","journal-title":"Biol Psychiatry"},{"key":"1454_CR102","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/aur.2520","volume":"14","author":"W Fyke","year":"2021","unstructured":"Fyke W, Alarcon JM, Velinov M, Chadman KK. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-alpha, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL\/J mice. Autism research: official journal of the International Society for. Autism Res. 2021;14:1375\u201389.","journal-title":"Autism Res"},{"key":"1454_CR103","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.euroneuro.2015.04.005","volume":"25","author":"A Manduca","year":"2015","unstructured":"Manduca A, Morena M, Campolongo P, Servadio M, Palmery M, Trabace L, et al. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats. Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol. 2015;25:1362\u201374.","journal-title":"Eur Neuropsychopharmacol: J Eur Coll Neuropsychopharmacol"},{"key":"1454_CR104","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s00213-019-05226-y","volume":"236","author":"S Schiavi","year":"2019","unstructured":"Schiavi S, Manduca A, Segatto M, Campolongo P, Pallottini V, Vanderschuren L, et al. Unidirectional opioid-cannabinoid cross-tolerance in the modulation of social play behavior in rats. Psychopharmacology. 2019;236:2557\u201368.\u00a0","journal-title":"Psychopharmacology"},{"key":"1454_CR105","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00213-016-4222-0","volume":"233","author":"D Wei","year":"2016","unstructured":"Wei D, Lee D, Li D, Daglian J, Jung KM, Piomelli D. A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice. Psychopharmacology. 2016;233:1911\u20139.","journal-title":"Psychopharmacology"},{"key":"1454_CR106","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/npp.2016.22","volume":"41","author":"A Manduca","year":"2016","unstructured":"Manduca A, Servadio M, Damsteegt R, Campolongo P, Vanderschuren LJ, Trezza V. Dopaminergic Neurotransmission in the Nucleus Accumbens Modulates Social Play Behavior in Rats. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2016;41:2215\u201323.","journal-title":"Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol."},{"key":"1454_CR107","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1172\/JCI131752","volume":"130","author":"OM Folkes","year":"2020","unstructured":"Folkes OM, Baldi R, Kondev V, Marcus DJ, Hartley ND, Turner BD, et al. An endocannabinoid-regulated basolateral amygdala-nucleus accumbens circuit modulates sociability. J Clin Investig. 2020;130:1728\u201342.","journal-title":"J Clin Investig"},{"key":"1454_CR108","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.conb.2011.04.005","volume":"21","author":"A Suvrathan","year":"2011","unstructured":"Suvrathan A, Chattarji S. Fragile X syndrome and the amygdala. Curr Opin Neurobiol. 2011;21:509\u201315.","journal-title":"Curr Opin Neurobiol"},{"key":"1454_CR109","doi-asserted-by":"publisher","first-page":"109805","DOI":"10.1016\/j.celrep.2021.109805","volume":"37","author":"G Fernandes","year":"2021","unstructured":"Fernandes G, Mishra PK, Nawaz MS, Donlin-Asp PG, Rahman MM, Hazra A, et al. Correction of amygdalar dysfunction in a rat model of fragile X syndrome. Cell Rep. 2021;37:109805.","journal-title":"Cell Rep."},{"key":"1454_CR110","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/brain\/awl338","volume":"130","author":"D Hessl","year":"2007","unstructured":"Hessl D, Rivera S, Koldewyn K, Cordeiro L, Adams J, Tassone F, et al. Amygdala dysfunction in men with the fragile X premutation. Brain: J Neurol. 2007;130:404\u201316.","journal-title":"Brain: J Neurol"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01454-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01454-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:04:42Z","timestamp":1683122682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-022-01454-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":110,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1038\/s41386-022-01454-7","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"3 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}